Truist Securities Reiterates NuCana (NCNA) at Buy, NuTide:121 is Not Central to Thesis, Plenty of Cash Runway to Complete Other Studies
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas reiterated a Buy rating and $22.00 price target on NuCana (NASDAQ: NCNA), following announcement of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
